Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cutaneous leishmaniasis treatment comparison with cryotherapy and intralesional meglumine antimoniate
IRCT138903063862N4Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of meglumine antimoniate in cutaneous leishmaniasis (CL) (3 arms), sponsored by Mashhad University of Medical Sciences. Started Nov 2008; status: completed.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT138903063862N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138903063862N4.